Biohit Oyj Future Growth
Future criteria checks 2/6
Biohit Oyj is forecast to grow earnings and revenue by 8.9% and 12.9% per annum respectively. EPS is expected to grow by 8.2% per annum. Return on equity is forecast to be 15.8% in 3 years.
Key information
8.9%
Earnings growth rate
8.2%
EPS growth rate
| Medical Equipment earnings growth | 24.4% |
| Revenue growth rate | 12.9% |
| Future return on equity | 15.8% |
| Analyst coverage | Low |
| Last updated | 08 Apr 2024 |
Recent future growth updates
Recent updates
Biohit Oyj's (HEL:BIOBV) Solid Profits Have Weak Fundamentals
Feb 22
Biohit Oyj Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Feb 17Companies Like Biohit Oyj (HEL:BIOBV) Are In A Position To Invest In Growth
Aug 04Companies Like Biohit Oyj (HEL:BIOBV) Are In A Position To Invest In Growth
Feb 09Biohit Oyj (HEL:BIOBV) Is In A Strong Position To Grow Its Business
Aug 11Biohit Oyj (HEL:BIOBV) Is In A Strong Position To Grow Its Business
Apr 13We Think Biohit Oyj (HEL:BIOBV) Can Afford To Drive Business Growth
Dec 28Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 20 | 2 | 2 | 3 | 1 |
| 12/31/2025 | 17 | 2 | 2 | 2 | 1 |
| 12/31/2024 | 15 | 2 | 4 | 4 | 1 |
| 12/31/2023 | 13 | 2 | 1 | 1 | N/A |
| 9/30/2023 | 12 | 1 | 0 | 1 | N/A |
| 6/30/2023 | 11 | 1 | 0 | 0 | N/A |
| 3/31/2023 | 11 | 1 | 1 | 1 | N/A |
| 12/31/2022 | 11 | 1 | 2 | 2 | N/A |
| 9/30/2022 | 11 | 1 | 1 | 1 | N/A |
| 6/30/2022 | 11 | 1 | 1 | 1 | N/A |
| 3/31/2022 | 10 | 0 | 0 | 0 | N/A |
| 12/31/2021 | 9 | -1 | 0 | 0 | N/A |
| 9/30/2021 | 9 | -2 | 0 | 0 | N/A |
| 6/30/2021 | 8 | -2 | 0 | 0 | N/A |
| 3/31/2021 | 8 | -3 | 0 | 0 | N/A |
| 12/31/2020 | 7 | -3 | 0 | 0 | N/A |
| 9/30/2020 | 8 | -3 | 0 | 0 | N/A |
| 6/30/2020 | 8 | -3 | 0 | 0 | N/A |
| 3/31/2020 | 9 | -2 | 0 | 0 | N/A |
| 12/31/2019 | 10 | -1 | 0 | 0 | N/A |
| 9/30/2019 | 10 | -2 | 0 | 0 | N/A |
| 6/30/2019 | 10 | -2 | 0 | 0 | N/A |
| 3/31/2019 | 10 | -2 | 0 | 0 | N/A |
| 12/31/2018 | 10 | -2 | 0 | 0 | N/A |
| 9/30/2018 | 10 | -2 | 0 | 0 | N/A |
| 6/30/2018 | 10 | -2 | 0 | 0 | N/A |
| 3/31/2018 | 9 | 2 | -1 | -1 | N/A |
| 12/31/2017 | 9 | 6 | -1 | -1 | N/A |
| 9/30/2017 | 9 | 6 | N/A | -1 | N/A |
| 6/30/2017 | 8 | 6 | N/A | -2 | N/A |
| 3/31/2017 | 8 | 1 | N/A | -2 | N/A |
| 12/31/2016 | 8 | -3 | N/A | -2 | N/A |
| 9/30/2016 | 7 | -4 | N/A | -3 | N/A |
| 6/30/2016 | 6 | -4 | N/A | -3 | N/A |
| 3/31/2016 | 7 | -3 | N/A | -3 | N/A |
| 12/31/2015 | 6 | -3 | N/A | -3 | N/A |
| 9/30/2015 | 6 | -3 | N/A | -2 | N/A |
| 6/30/2015 | 6 | -4 | N/A | -3 | N/A |
| 3/31/2015 | 5 | -4 | N/A | -4 | N/A |
| 12/31/2014 | 4 | -4 | N/A | -3 | N/A |
| 9/30/2014 | 4 | -5 | N/A | -4 | N/A |
| 6/30/2014 | 4 | -5 | N/A | -4 | N/A |
| 3/31/2014 | 4 | -6 | N/A | -4 | N/A |
| 12/31/2013 | 3 | -6 | N/A | -4 | N/A |
| 9/30/2013 | 3 | -5 | N/A | -4 | N/A |
| 6/30/2013 | 3 | -5 | N/A | -4 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: BIOBV's forecast earnings growth (8.9% per year) is above the savings rate (1%).
Earnings vs Market: BIOBV's earnings (8.9% per year) are forecast to grow slower than the Finnish market (16% per year).
High Growth Earnings: BIOBV's earnings are forecast to grow, but not significantly.
Revenue vs Market: BIOBV's revenue (12.9% per year) is forecast to grow faster than the Finnish market (2.6% per year).
High Growth Revenue: BIOBV's revenue (12.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: BIOBV's Return on Equity is forecast to be low in 3 years time (15.8%).